Clinical Trial

Interleukin-6 in the Development of Meconium Aspiration Syndrome in Newborn

Completed
View on ClinicalTrials.gov →
Summary
This trial is intended to assess the serum levels of interleukin-6 as a predictive factor for the occurrence of meconium aspiration syndrome in infants born with MSAF.
Trial Details
NCT Number NCT07394322
Lead Sponsor Benha University
Conditions Meconium Aspiration Syndrome
Enrollment 120 participants
Start Date 2023-01-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-06